All In Biotech

Drug Trial Radar · NCT00003140

Letrozole After Tamoxifen in Treating Women With Breast Cancer

A Phase III Randomized Double Blind Study of Letrozole Versus Placebo in Women With Primary Breast Cancer Completing Five or More Years of Adjuvant Tamoxifen

Last checked: Nov 20, 2026Latest source record: Mar 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 5,187 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

5,187

Actual

Start

Aug 24, 1998

Primary completion

Aug 22, 2003

Study completion Oct 2003

Sponsor

Lead sponsor
NCIC Clinical Trials GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI); North Central Cancer Treatment Group; ETOP IBCSG Partners Foundation; Eastern Cooperative Oncology Group; SWOG Cancer Research Network; Cancer and Leukemia Group B; European Organisation for Research and Treatment of Cancer - EORTC
First posted
Jan 27, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Female only, from 0 years, up to 120 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer by reducing the production of estrogen. PURPOSE: This randomized phase III trial is studying letrozole to see how well it works in treating women with breast cancer who have received tamoxifen for at least 5 years.

Conditions

  • Breast Cancer

Interventions

  • letrozoleDrug

    Given orally

  • placeboOther

    Given orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Disease-free survivalTime frame: 5 years

Locations

57 sites in 2 countries. Site status is shown where the registry gives one.

  • Lethbridge Cancer Centre

    Lethbridge, Alberta, Canada

  • BCCA - Cancer Centre for the Southern Interior

    Kelowna, British Columbia, Canada

  • NRGH - Nanaimo Cancer Clinic

    Nanaimo, British Columbia, Canada

  • Penticton Regional Hospital

    Penticton, British Columbia, Canada

  • BCCA - Fraser Valley Cancer Centre

    Surrey, British Columbia, Canada

  • BCCA - Vancouver Cancer Centre

    Vancouver, British Columbia, Canada

  • BCCA - Vancouver Island Cancer Centre

    Victoria, British Columbia, Canada

  • CancerCare Manitoba

    Winnipeg, Manitoba, Canada

  • The Moncton Hospital

    Moncton, New Brunswick, Canada

  • The Vitalite Health Network - Dr. Leon Richard

    Moncton, New Brunswick, Canada

  • Atlantic Health Sciences Corporation

    Saint John, New Brunswick, Canada

  • Dr. H. Bliss Murphy Cancer Centre

    St. John's, Newfoundland and Labrador, Canada

  • QEII Health Sciences Center

    Halifax, Nova Scotia, Canada

  • The Royal Victoria Hospital

    Barrie, Ontario, Canada

  • Regional Cancer Program of the Hopital Regional

    Greater Sudbury, Ontario, Canada

  • Juravinski Cancer Centre at Hamilton Health Sciences

    Hamilton, Ontario, Canada

  • Cancer Centre of Southeastern Ontario at Kingston

    Kingston, Ontario, Canada

  • London Regional Cancer Program

    London, Ontario, Canada

  • Markham Stouffville Hospital

    Markham, Ontario, Canada

  • Credit Valley Hospital

    Mississauga, Ontario, Canada

  • Stronach Regional Health Centre at Southlake

    Newmarket, Ontario, Canada

  • Lakeridge Health Oshawa

    Oshawa, Ontario, Canada

  • Ottawa Health Research Institute - General Division

    Ottawa, Ontario, Canada

  • Peterborough Regional Health Centre

    Peterborough, Ontario, Canada

  • Algoma District Cancer Program

    Sault Ste. Marie, Ontario, Canada

  • Niagara Health System

    St. Catharines, Ontario, Canada

  • Thunder Bay Regional Health Science Centre

    Thunder Bay, Ontario, Canada

  • North York General Hospital

    Toronto, Ontario, Canada

  • Toronto East General Hospital

    Toronto, Ontario, Canada

  • Odette Cancer Centre

    Toronto, Ontario, Canada

  • St. Michael's Hospital

    Toronto, Ontario, Canada

  • Mount Sinai Hospital

    Toronto, Ontario, Canada

  • Univ. Health Network-The Toronto General Hospital

    Toronto, Ontario, Canada

  • Univ. Health Network-Princess Margaret Hospital

    Toronto, Ontario, Canada

  • St. Joseph's Health Centre

    Toronto, Ontario, Canada

  • Trillium Health Centre - West Toronto

    Toronto, Ontario, Canada

  • Humber River Regional Hospital

    Toronto, Ontario, Canada

  • Windsor Regional Cancer Centre

    Windsor, Ontario, Canada

  • PEI Cancer Treatment Centre,Queen Elizabeth Hospital

    Charlottetown, Prince Edward Island, Canada

  • Centre de Sante et de services sociaux de Gatineau

    Gatineau, Quebec, Canada

Showing 40 of 57 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.